Everand Logo

Welcome to Everand!

  • STAT

    Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome

    Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug? Find out on the latest episode of "The Readout…
    by Damian Garde and Rebecca Robbins and Adam Feuerstein Feb 20, 2020 1 minute

    Can biopharma police itself? Who decides whether something’s a disease or a difference? And will fecal matter ever become a drug?

    We discuss all that and more on the latest

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: No, Alcohol Isn’t Good For You. Will New Dietary Guidelines Be Shaped More By Health Or Industry Interests?
    More and more studies show that alcohol isn't healthy after all. Dietary guidelines are up for revision in 2025, and already, there's debate over research and industry influence.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT1 min read
    STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
    Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.

    Related